Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effective treatment of diabetes caused by activating ABCC8/SUR1 mutation with glimepiride.

Diabetic medicine : a journal of the British Diabetic Association - 1 May 2012

Karges B, Schnur D, Ellard S, Kentrup H, Karges W

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP-Binding Cassette Transporters
Share to Diabetes Mellitus, Type 1
Share to Hypoglycemic Agents
Share to Infant, Newborn

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Potassium Channels, Inwardly Rectifying

Share to Receptors, Drug

Share to Sulfonylurea Compounds

Share to Sulfonylurea Receptors

Source

Identifiers

PMID: 21992555
DOI: 10.1111/j.1464-5491.2011.03487.x

Genes

ABCC8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effective treatment of diabetes caused by activating ABCC8/SUR1 mutation with glimepiride.PMID 21992555Read ↗

Incretin effect of glucagon-like peptide 1 receptor agonist is preserved in presence of ABCC8/SUR1 mutation in β-cell.Semantic proximity Read ↗

Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive Update.Semantic proximity Read ↗

Clinical and Genetic Characteristics of ABCC8 Nonneonatal Diabetes Mellitus: A Systematic Review.Semantic proximity Read ↗

ABCC8 genetic variants and risk of diabetes mellitus.Semantic proximity Read ↗

Highlights from the latest articles in diabetes pharmacogenomics.Semantic proximity Read ↗

Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC 8 gene: response to appropriate therapySemantic proximity Read ↗

Dominant SUR1 mutation causing autosomal dominant type 2 diabetes.Semantic proximity Read ↗

Pharmacogenetics of Oral Antidiabetic DrugsSemantic proximity Read ↗

Current therapies and targets for type 2 diabetes mellitusSemantic proximity Read ↗

Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patientsSemantic proximity Read ↗

The Shifting Landscape of K<sub>Atp</sub>Channelopathies and the Need for ‘Sharper’ TherapeuticsSemantic proximity Read ↗

Long-term efficacy of glibenclamide and sitagliptin therapy in adult patients with KCNJ11 permanent diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.